Delivery Order SPE2DB22D1106-SPE2DB25FEKK4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,554.79 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This firm fixed-price contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $7,981.55 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, issued on August 8, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,249.60 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.97 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $1,411.51. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. Sumatriptan is a migraine treatment...
- The Defense Logistics Agency awarded a delivery order valued at $3,137.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, awarded on July 23, 2025, with a completion date of July 24, 2025, utilizes firm fixed pricing with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injectors valued at $5,364.64 under firm fixed-price terms. The award was issued on November 4, 2025, with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive procurement utilizing an existing contract vehicle rather than a new...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units valued at $1,129.39, with an ultimate completion date of August 20, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery contract (IDC) vehicle. The pharmaceutical product will be performed and delivered from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,621.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on November 5, 2025, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract involves no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a $18,468.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 ml auto-injector units, with a completion date of September 11, 2025. The award was made on September 10, 2025, with no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEKK4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,248.57 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 ml auto-injector units. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a firm fixed price delivery order with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement running through December 2026 that enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies medications, vaccines, medical devices, and specialized commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated its capability to meet federal procurement requirements through competitive award processes, with its DLA contract portfolio reflecting extensive experience fulfilling pharmaceutical needs ranging from small-value transactions to orders exceeding $45,000. The current delivery order for Sumatriptan represents a routine execution of the company's broader supply commitment to support military medical logistics and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/24/25 |